BACKGROUND: The etiology of Hodgkin lymphoma (HL) remains incompletely characterized. Studies of the association between smoking and HL have yielded ambiguous results, possibly due to differences between HL subtypes. PATIENTS AND METHODS: Through the InterLymph Consortium, 12 case-control studies regarding cigarette smoking and HL were identified. Pooled analyses on the association between smoking and HL stratified by tumor histology and Epstein-Barr virus (EBV) status were conducted using random effects models adjusted for confounders. Analyses included 3335 HL cases and 14 278 controls. RESULTS: Overall, 54.5% of cases and 57.4% of controls were ever cigarette smokers. Compared with never smokers, ever smokers had an odds ratio (OR) of HL of 1.10 [95% confidence interval (CI) 1.01-1.21]. This increased risk reflected associations with mixed cellularity cHL (OR = 1.60, 95% CI 1.29-1.99) and EBV-positive cHL (OR = 1.81, 95% CI 1.27-2.56) among current smokers, whereas risk of nodular sclerosis (OR = 1.09, 95% CI 0.90-1.32) and EBV-negative HL (OR = 1.02, 95% CI 0.72-1.44) was not increased. CONCLUSION: These results support the notion of etiologic heterogeneity between HL subtypes, highlighting the need for HL stratification in future studies. Even if not relevant to all subtypes, our study emphasizes that cigarette smoking should be added to the few modifiable HL risk factors identified.
BACKGROUND: The etiology of Hodgkin lymphoma (HL) remains incompletely characterized. Studies of the association between smoking and HL have yielded ambiguous results, possibly due to differences between HL subtypes. PATIENTS AND METHODS: Through the InterLymph Consortium, 12 case-control studies regarding cigarette smoking and HL were identified. Pooled analyses on the association between smoking and HL stratified by tumor histology and Epstein-Barr virus (EBV) status were conducted using random effects models adjusted for confounders. Analyses included 3335 HL cases and 14 278 controls. RESULTS: Overall, 54.5% of cases and 57.4% of controls were ever cigarette smokers. Compared with never smokers, ever smokers had an odds ratio (OR) of HL of 1.10 [95% confidence interval (CI) 1.01-1.21]. This increased risk reflected associations with mixed cellularity cHL (OR = 1.60, 95% CI 1.29-1.99) and EBV-positive cHL (OR = 1.81, 95% CI 1.27-2.56) among current smokers, whereas risk of nodular sclerosis (OR = 1.09, 95% CI 0.90-1.32) and EBV-negative HL (OR = 1.02, 95% CI 0.72-1.44) was not increased. CONCLUSION: These results support the notion of etiologic heterogeneity between HL subtypes, highlighting the need for HL stratification in future studies. Even if not relevant to all subtypes, our study emphasizes that cigarette smoking should be added to the few modifiable HL risk factors identified.
Authors: E Stagnaro; V Ramazzotti; P Crosignani; A Fontana; G Masala; L Miligi; O Nanni; M Neri; S Rodella; A S Costantini; R Tumino; C Viganò; C Vindigni; P Vineis Journal: Cancer Causes Control Date: 2001-05 Impact factor: 2.506
Authors: Nathaniel C Briggs; H Irene Hall; Edward A Brann; Cynthia J Moriarty; Robert S Levine Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye Journal: N Engl J Med Date: 2003-10-02 Impact factor: 91.245
Authors: M Constanza Camargo; Chihaya Koriyama; Keitaro Matsuo; Woo-Ho Kim; Roberto Herrera-Goepfert; Linda M Liao; Jun Yu; Gabriel Carrasquilla; Joseph J Y Sung; Isabel Alvarado-Cabrero; Jolanta Lissowska; Fernando Meneses-Gonzalez; Yashushi Yatabe; Ti Ding; Nan Hu; Philip R Taylor; Douglas R Morgan; Margaret L Gulley; Javier Torres; Suminori Akiba; Charles S Rabkin Journal: Int J Cancer Date: 2013-08-28 Impact factor: 7.396
Authors: Dai Chihara; Loretta J Nastoupil; Jessica N Williams; Paul Lee; Jean L Koff; Christopher R Flowers Journal: Expert Rev Anticancer Ther Date: 2015-04-11 Impact factor: 4.512
Authors: Leah Shepherd; Lene Ryom; Matthew Law; Camilla Ingrid Hatleberg; Stephane de Wit; Antonella d'Arminio Monforte; Manuel Battegay; Andrew Phillips; Fabrice Bonnet; Peter Reiss; Christian Pradier; Andrew Grulich; Caroline Sabin; Jens Lundgren; Amanda Mocroft Journal: J Natl Cancer Inst Date: 2018-06-01 Impact factor: 13.506
Authors: Yu-Han Chiu; Kimberly A Bertrand; Shumin Zhang; Francine Laden; Mara M Epstein; Bernard A Rosner; Stephanie Chiuve; Hannia Campos; Edward L Giovannucci; Jorge E Chavarro; Brenda M Birmann Journal: Int J Cancer Date: 2018-08-10 Impact factor: 7.396
Authors: Peter Hollander; Klaus Rostgaard; Karin E Smedby; Ellen T Chang; Rose-Marie Amini; Peter de Nully Brown; Bengt Glimelius; Hans-Olov Adami; Mads Melbye; Ingrid Glimelius; Henrik Hjalgrim Journal: Am J Epidemiol Date: 2015-09-06 Impact factor: 4.897
Authors: Sally L Glaser; Christina A Clarke; Theresa H M Keegan; Ellen T Chang; Dennis D Weisenburger Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-07-27 Impact factor: 4.090
Authors: Panagiotis Georgiadis; Dennie G Hebels; Ioannis Valavanis; Irene Liampa; Ingvar A Bergdahl; Anders Johansson; Domenico Palli; Marc Chadeau-Hyam; Aristotelis Chatziioannou; Danyel G J Jennen; Julian Krauskopf; Marlon J Jetten; Jos C S Kleinjans; Paolo Vineis; Soterios A Kyrtopoulos Journal: Sci Rep Date: 2016-02-03 Impact factor: 4.379